Bioavailability and Bioequivalence

Pharma Clinical Trials

Clinical trials are used to evaluate potential treatments that have had some effect against disease in the lab, or in animal experiments. The whole point of a clinical trial is to find out if a treatment is effective. The aim of clinical trials is to determine if a treatment works and is safe. By comparing similar groups of people taking different treatments for the same disease it is possible to show whether any benefits are due to the treatment. Effective treatments identified in this way may then become standard practice. Since the research is experimental, those who take part in early studies may not always benefit. Once a new approach has been proven safe and effective in a clinical trial, it may become standard practice. Standard practice is a currently accepted and widely used approach and would require approval by a government body such as the FDA or EMEA.

The market of clinical trials in India is predicted to reach at a CAGR of nearly 36% between 2006–2011 to gain revenues worth US $ 546 Million in future. The Prime advantage of conducting clinical trials in India is the availability of a huge patient pool that can be initiated at much lower time then it takes to recruit patients in the west.